# PSA (Pharachute Supralaryngeal Airway) for Positive Pressure Ventilation (PPV)

> **NCT04258215** · NA · WITHDRAWN · sponsor: **Hull University Teaching Hospitals NHS Trust**

## Conditions studied

- Airway Control

## Interventions

- **DEVICE:** Experimental: Routine positive pressure airway management.

## Key facts

- **NCT ID:** NCT04258215
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID
- **Last updated:** 2022-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04258215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04258215, "PSA (Pharachute Supralaryngeal Airway) for Positive Pressure Ventilation (PPV)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04258215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*